We’re delighted to see the regional press Schwäbische highlighting our recent partnership with Ackermann. Another great example of how SHS Capital supports entrepreneurs when succession within the family isn’t an option. Together, we’ve created a solution that safeguards the company’s legacy, drives future growth, and keeps its values at the heart of the business. As […]

AMW GmbH, a pharmaceutical company specialising in biodegradable implants, has initiated a research and development project aimed at increasing the efficiency of formulation development through the use of AI. The project is being scientifically supported by the research group of Prof. Dr. Olivia Merkel (LMU Munich), an expert in the field of drug delivery. The […]

A study conducted at the University of Helsinki and Helsinki University Hospital has evaluated the performance of the MESI mTABLET TBI toe pressure photoplethysmography device against a stationary laser Doppler flow meter, the current gold standard for assessing superficial microvessels. The University of Helsinki study shows that the MESI mTABLET TBI demonstrates high concordance with […]

We are delighted that the new product RoTecPSMA® from our portfolio company ROTOP has received marketing authorisation in the UK. RoTecPSMA® is a diagnostic kit that uses technetium-99m and has been specially developed for SPECT imaging in prostate cancer patients. It is the first PSMA SPECT tracer to be approved in a European country. It […]

At its 181st meeting in March 2025, the European Pharmacopoeia Commission (EPC) adopted a new general chapter entitled ” High-throughput sequencing for the detection of viral extraneous agents (2.6.41)”. The new chapter will be published in edition 12.2 of the European Pharmacopoeia (Ph. Eur.) in October 2025 and will enter into force on 1 April […]

SHS Capital recently hosted another Portfolio Workshop, bringing together executives from SHS portfolio companies to discuss how to promote effective leadership, scale businesses efficiently and manage growth in dynamic markets. Under the expert moderation of Thalia Ucksche, Bernhard Stieger and Alexander Liolios from Spencer Stuart, the workshop focused on the changing requirements of scaling companies […]

The annual SHS Investors’ Day took place again this year in Tübingen. Investors, portfolio representatives, senior advisors, healthcare experts and other valued guests were warmly welcomed at the Hotel Krone in the heart of Tübingen. The day offered engaging presentations on healthcare topics and an outlook on economic development and medical innovations over the coming […]

Rietheim-Weilheim / Tübingen, 8 July 2025 Healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The investment aims to expand Ackermann’s core business and, through partnerships and acquisitions of additional companies, build a leading, globally positioned MedTech group. Ackermann Instrumente GmbH, headquartered near Tuttlingen, is a leading manufacturer of high-quality surgical […]

Tuebingen / 13.03.2025 Selfapy GmbH, a digital health pioneer in the field of mental health, has been acquired by MEDICE Health Family, the European market leader in ADHD therapy. As part of the transaction, the investors SHS Capital, Think.Health Ventures, IBB Ventures, and HTGF sold their shares. Selfapy’s CE-certified medical products provide flexible and easily […]

Tuebingen / 13.02.2025 Healthcare specialist SHS Capital has taken an important step in its long-term succession planning and is securing further growth. Lukas Maucher, who joined SHS in 2022 from one of the Big Four auditing firms and has served as CFO since then, will take on the role of Managing Partner, overseeing finance and […]

InnoRa GmbH contributes over 20 years of experience in the development of innovative cardiovascular devices and their translation into clinical trials to the partnership. The partnership also includes an undisclosed investment by InnoRa. Professor Bruno Scheller, a renowned expert in interventional cardiology and co-founder of InnoRa will join the Supervisory Board of CoreMedic.Josef Bogenschütz, CEO […]

Maya combines robotic, sensor-based and MTT (Medical Training Therapy) devices on a seamless platform that optimises therapy for upper and lower extremities. By connecting all Tyromotion devices, Maya provides a complete overview of the patient’s progress, making therapy more efficient and coordinated.In rehabilitation, it is crucial to focus on the patient’s individual goals. With Maya, […]